Related Experiment Video
Updated: Jun 14, 2025
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.1K
Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis
Yao Yao1, Xiaoyu Cai2, Yue Chen1
1Department of Pharmacy, Women's Hospital School of Medicine Zhejiang University, Hangzhou, China.
Medicinal Research Reviews
|September 5, 2024
Summary
Postmenopausal osteoporosis (PMO) involves bone loss due to estrogen deficiency impacting bone cells and immune responses. This review details the osteoimmunology mechanisms underlying PMO, crucial for understanding bone health.
Area of Science:
- Immunology
- Endocrinology
- Bone Biology
Background:
- Postmenopausal osteoporosis (PMO) is a prevalent aging-related condition.
- Estrogen deficiency is a primary driver of PMO, affecting bone cell activity.
- Emerging evidence highlights a significant role for osteoimmunology in PMO pathogenesis.
Purpose of the Study:
- To systematically review the mechanisms of bone loss in PMO.
- To elucidate the role of estrogen deficiency-mediated osteoimmunity in PMO.
- To compare immune cell activity in PMO patients versus non-osteoporotic postmenopausal women.
Main Methods:
- Literature review of osteoimmunology and PMO.
- Analysis of estrogen deficiency effects on bone cells.
- Examination of immune cell (T cells, B cells, macrophages, neutrophils, dendritic cells, mast cells) activity in PMO.
Main Results:
- Estrogen deficiency directly impacts osteoblasts, osteoclasts, and osteocytes.
- Estrogen deficiency-mediated immune responses significantly contribute to bone loss in PMO.
- Distinct immune cell profiles are observed in PMO patients compared to controls.
Conclusions:
- Osteoimmunology is a critical factor in postmenopausal osteoporosis.
- Understanding estrogen deficiency-mediated immune cell activity is key to PMO research.
- This review provides a framework for future investigations into PMO mechanisms.
Related Concept Videos
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:28Menopause
146
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
146
01:40Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
02:07Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
01:25Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K